Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Asset Utilization Ratio (2021 - 2025)

Oncology Institute (TOI) has disclosed Asset Utilization Ratio for 5 consecutive years, with 2.85 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio rose 34.97% year-over-year to 2.85, compared with a TTM value of 2.85 through Sep 2025, up 34.97%, and an annual FY2024 reading of 2.06, up 49.59% over the prior year.
  • Asset Utilization Ratio was 2.85 for Q3 2025 at Oncology Institute, up from 2.62 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 2.85 in Q3 2025 and bottomed at 0.33 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 1.44, with a median of 1.26 recorded in 2023.
  • Peak annual rise in Asset Utilization Ratio hit 212.26% in 2022, while the deepest fall reached 1.1% in 2022.
  • Year by year, Asset Utilization Ratio stood at 0.94 in 2021, then decreased by 1.1% to 0.93 in 2022, then skyrocketed by 63.82% to 1.52 in 2023, then soared by 47.43% to 2.24 in 2024, then grew by 27.51% to 2.85 in 2025.
  • Business Quant data shows Asset Utilization Ratio for TOI at 2.85 in Q3 2025, 2.62 in Q2 2025, and 2.39 in Q1 2025.